These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15241828)

  • 21. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
    Chua DT; Sham JS; Kwong DL; Choy DT; Au GK; Wu PM
    Cancer; 1996 Jul; 78(2):202-10. PubMed ID: 8673993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy.
    Serkies K; Badzio A; Jassem J
    Acta Oncol; 2006; 45(6):695-701. PubMed ID: 16938812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
    Gauthier I; Ding K; Winton T; Shepherd FA; Livingston R; Johnson DH; Rigas JR; Whitehead M; Graham B; Seymour L
    Lung Cancer; 2007 Mar; 55(3):357-63. PubMed ID: 17141357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
    Chua DT; Sham JS; Kwong DL; Au GK
    Cancer; 2003 Jul; 98(1):74-80. PubMed ID: 12833458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
    Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
    Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P
    Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
    Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
    J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
    Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW
    Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
    Chu ST; Wu PH; Chou P; Lee CC
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.